Integrated care is a slogan. It seems like a high principle, but it is really a ruse or gross exaggeration in most cases, especially when behavioral health is on the table.
New approaches to reimbursement for opioid addiction treatment might include measures of evidence-based care protocols as well as patient outcomes.
The changing behavioral health market might leave small, not-for-profit operators wondering how they can possibly compete. Experts suggest a new affiliation model.
As more behavioral healthcare services are offered to meet demand, and as expectations rise for better outcomes and lower costs, this will of necessity lead to measurement—of access, outcome and cost.
Existing privacy rules are too cumbersome for today’s integrated world, say proponents of change to 42 CFR Part 2, while others argue that the new privacy rule changes are too broad.
Federal health leaders say Medicare has already met its goal with 30% of payments now tied to value-based models. Meanwhile, commercial insurers, health systems, employers and organizations have kept a similar pace.
Cost management and quality outcomes will be critical for treatment centers that hope to stay in the black under new value-based reimbursement arrangements.
ACOs have become one of the most talked about new ideas in the Affordable Care Act. Here are answers to some common questions about how they work.
With serious cash on the line, hospitals are in need of willing partners to help in managing the overall health of Medicare patients.
The business case for integration is in the cost savings as well as patient and provider satisfaction. But making such a change can be hard.
Treatment Research Institute adviser David Gastfriend, MD, says the SBIRT model should be turned on its head.
Mental health and substance use treatment providers must learn to speak the language of other stakeholders and play a role in population health initiatives.
View issues archive
Get the Digital Edition